Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Phibro Animal Health (PAHC) Invested Capital: 2013-2025

Historic Invested Capital for Phibro Animal Health (PAHC) over the last 12 years, with Sep 2025 value amounting to $330.1 million.

  • Phibro Animal Health's Invested Capital rose 24.09% to $330.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $330.1 million, marking a year-over-year increase of 24.09%. This contributed to the annual value of $301.9 million for FY2025, which is 5.41% up from last year.
  • Latest data reveals that Phibro Animal Health reported Invested Capital of $330.1 million as of Q3 2025, which was up 9.34% from $301.9 million recorded in Q2 2025.
  • Over the past 5 years, Phibro Animal Health's Invested Capital peaked at $330.1 million during Q3 2025, and registered a low of $239.4 million during Q1 2021.
  • Its 3-year average for Invested Capital is $292.4 million, with a median of $296.8 million in 2023.
  • Its Invested Capital has fluctuated over the past 5 years, first declined by 11.38% in 2024, then increased by 24.09% in 2025.
  • Over the past 5 years, Phibro Animal Health's Invested Capital (Quarterly) stood at $252.4 million in 2021, then climbed by 12.43% to $283.8 million in 2022, then increased by 4.60% to $296.8 million in 2023, then dropped by 11.38% to $263.1 million in 2024, then climbed by 24.09% to $330.1 million in 2025.
  • Its Invested Capital was $330.1 million in Q3 2025, compared to $301.9 million in Q2 2025 and $282.2 million in Q1 2025.